$0.91+0.01 (+1.27%)
Lite Strategy, Inc.
Lite Strategy, Inc. in the Healthcare sector is trading at $0.91 with a market capitalization of $28M. The stock is currently near its 52-week low of $0.69, remaining 38.6% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | β | β | β | β | β |
| Operating Income | -$2.77Mβ | -$3.35Mβ | -$3.11Mβ | -$2.88Mβ | -$2.77M |
| Net Income | -$23.69Mβ | -$30.80Mβ | -$3.64Mβ | -$2.69Mβ | -$2.57M |
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. ...
LitVM aims to bring smart contracts and DeFi capabilities to Litecoin without altering Litecoin's base-layer design as a simple payments network. Nasdaq-listed Lite Strategy ...
Investing.com -- Lite Strategy, the first U.S. public company to hold Litecoin as its primary treasury reserve asset, will announce Thursday that it has closed a $1 million lead strategic investment in ZK Innovations Inc, Investing.com has learned.
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...